Ticker LaunchUplisting · CELZ
Creative Medical Technology Holdings, Inc.
Formerly JOLLEY MARKETING INC
Creative Medical Technology Holdings, Inc. (CELZ), already reporting to the SEC, moved up to Nasdaq Capital Market on Dec 6, 2021 with an offering at $4.13 per share raising $16M. Roth Capital was lead-left underwriter. Fox Rothschild advised the company.
Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company using adult stem cell treatments and related regenerative technologies in immunology, urology, neurology and orthopedics. Its subsidiary was formed to monetize a patent for treating erectile dysfunction.
- Status
- Uplisting
- Ticker
- CELZ
- Exchange
- Nasdaq Capital Market
- Listed
- Dec 6, 2021
- Price
- $4.13
- Raised
- $16M
- Market cap at IPO price
- $26.1M
- First filed
- Nov 5, 2008
- Underwriters
- Roth Capital
- Company counsel
- Fox Rothschild
- Sector
- Biotech & pharma
- Country / state
- AZ
More on this listing for subscribers
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Nov 5, 2008
- Latest amendment Dec 2, 2021
- Final prospectus (424B4) Dec 6, 2021
- All filings on EDGAR CIK 1187953
Other Biotech & pharma uplistings in 2021
- Evotec SEEVO · Nov 5, 2021 · $435M
- Zivo Bioscience, Inc.ZIVO · Jun 1, 2021 · $13.8M
- Nexentis Technologies Inc.SVFD · May 17, 2021 · $12M
- Protagenic Therapeutics, Inc.\newPTIX · Apr 28, 2021 · $13.2M
- GT Biopharma, Inc.GTBP · Feb 12, 2021 · $23.6M
- Lexaria Bioscience Corp.LEXX · Jan 14, 2021 · $9.6M